A new set‐up of vanishing antibodies: A biennial follow‐up of five different clients' humoral responses against SARS‐CoV‐2 after systemic vaccination in an oncology hospital in Poland
- 30 March 2023
- journal article
- editorial
- Published by Wiley in Health Science Reports
- Vol. 6 (4) , e1172
Abstract
No abstract availableKeywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH ProjectMedicina, 2021
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Progression from Pneumonia to ARDS as a Predictor for Fatal COVID-19Journal of Infection and Public Health, 2021
- Correlates of Vaccine-Induced Protection against SARS-CoV-2Vaccines, 2021
- Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samplesJournal of Immunological Methods, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide RegisterJournal of Clinical Medicine, 2020
- Convergent antibody responses to SARS-CoV-2 in convalescent individualsNature, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020